Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
ICE Has Not Paid for Detainee Medical Care for 7 Months
On October 3 2025 the Trump administration halted reimbursements to third‑party providers for ICE detainee medical care, creating a seven‑month payment gap. The pause coincided with a sharp rise in detainee deaths, jumping from an average of 9 per year to 33 in 2025 and 18 in the first four months of 2026. Acentra Health, the new contractor, has delayed payments into the second quarter of 2026, while the Department of Veterans Affairs denies processing any claims despite public statements. The surge in mortality and anecdotal reports suggest systemic denial of essential health services.
The Federal Government Didn’t Legalize Marijuana. Here’s What Actually Changed.
On April 23 the Justice Department reclassified state‑licensed and FDA‑approved medical marijuana products from Schedule I to Schedule III. The move does not legalize cannabis federally but opens the door for tax deductions, retroactive refunds, and fewer research barriers. It signals a...
FDA Greenlights First Ibogaine Trial as Hype Eclipses Limited Data
The U.S. Food and Drug Administration announced it will permit the first clinical trial of ibogaine, a psychedelic derived from a West African shrub, after President Donald Trump highlighted the drug at a White House event. Researchers caution that the...
Heidi AI Expands to South Africa, Spurring Clinician‑led AI Adoption
Heidi AI has launched its clinician‑led AI platform across South Africa, reaching more than 1.5 million consultations each month and posting a 500% year‑on‑year rise in weekly active use. The expansion leverages seamless integration with local practice‑management systems and targets a...
Express Delegation Still Means What It Says: Sixth Circuit Upholds DOL Home Care Rule After Loper Bright
On April 1 2026 the Sixth Circuit upheld the Department of Labor’s 2013 rule that requires third‑party home‑care agencies to pay overtime, even for live‑in caregivers caring for family members. The court ruled that Congress’s express delegation of authority to the DOL...
The Reality of Social Security and Medicare- My Real Life Experience.
A retiree who paid $132,817 in Social Security taxes (1959‑2010) and an equal amount from his employer now reports receiving roughly $798,750 in combined benefits since 2008, surpassing his contributions after six years. He also paid $98,080 in Medicare taxes,...
Three Dead as Hantavirus Strikes Atlantic Cruise Ship, WHO Confirms
The World Health Organization confirmed that three passengers died and one case of hantavirus was laboratory‑verified on the MV Hondius, a Netherlands‑operated expedition cruise in the Atlantic. Six people fell ill, with two more evacuated for intensive care, sparking an...
Andalusia Unveils Ruthenium‑Uracil Nanoparticle Coating to Combat Hospital Superbugs
A team from the Instituto de Investigaciones Químicas, backed by the CSIC and the University of Sevilla, has created a ruthenium‑uracil nanoparticle that eliminates Staphylococcus aureus in lab tests. The breakthrough, funded by the Andalusian Ministry of University, Research and...
Kenya's AI Health Premiums Spike, Leaving Poor Families Unable to Pay
Kenya's AI‑powered health contribution system, launched in October 2024, is systematically inflating premiums for low‑income households, charging up to 20% of their income. The Guardian reports that families now face fees of 1,030 Kenyan shillings ($10) a year, sparking protests...
Should a California Union Dictate How Clinics Spend Money? Employers Sue to Block Ballot Measure
The Service Employees International Union‑United Healthcare Workers West (SEIU‑UHW) has qualified the Clinic Funding Accountability and Transparency Act for the November ballot after gathering more than one million signatures. The initiative would require federally qualified health centers to spend at...
Asembia ASX26: The ‘Entirely Pass-Through’ Business Model
At the Asembia ASX26 Summit, Aradigm Health CEO Will Shrank outlined the company’s “entirely pass‑through” business model, which charges only a transparent administrative fee and returns any surplus to purchasers as a dividend. The approach targets the opacity and waste...
AI Can't Fix Healthcare's Deep Structural Problems
AI is being positioned as a fix for healthcare. It won’t be that simple. Automation may reduce costs and speed up diagnoses, but it doesn’t solve deeper issues like staffing, funding and system complexity. The risk is clear. Technology can improve parts...
FDA Grants 510(k) Clearance to TaeWoong Medical for Spaxus EUS Stent
TaeWoong Medical received FDA 510(k) clearance for its Niti‑S Spaxus Stent, a fully covered, self‑expanding metallic device used in endoscopic ultrasound (EUS)‑guided drainage. The stent is approved for draining symptomatic pancreatic pseudocysts, walled‑off necrosis larger than 6 cm, and for gallbladder...
The Inflated Reality: Unmasking the Biological Cost of Modern Lip Augmentation
The American Society of Plastic Surgeons reported roughly 1.45 million lip‑augmentation procedures in the United States in 2024, indicating that 5‑10 % of adult women have undergone the treatment at least once. Modern practice relies chiefly on hyaluronic‑acid fillers that are chemically...
What Doctors Want You to Know About Cannabis and Health
President Trump recently loosened federal medical‑marijuana restrictions, prompting optimism among researchers for expanded studies. The FDA currently approves only a few cannabis‑derived drugs for chemotherapy‑induced nausea, AIDS‑related wasting, and seizures. Experts highlight that the strongest evidence supports modest pain relief,...
What to Know About Orphines, a New Class of Deadly Opioids
Orphines, a synthetic opioid class up to ten times more potent than fentanyl, have surfaced in U.S. street drugs since late 2023. They evade standard toxicology screens, making overdoses harder to detect and treat. By May 2026 they were identified...
The AI Knowledge Gap We Can’t Afford to Ignore
Healthcare is rapidly integrating artificial intelligence, with two‑thirds of physicians using AI tools in 2024—a 78% surge from previous years. While AI can streamline chart review and surface clinical trends, experts warn that overreliance creates automation bias, magnifying documentation flaws...
What Is Your AI Drug Repurposing Strategy Missing?
The article argues that AI‑driven drug repurposing for oncology often fails because models are fed fragmented, noisy data despite abundant datasets. It stresses that more data alone won’t improve outcomes; instead, high‑quality, curated, structured data—such as knowledge graphs linking genes,...
A Study Of 4 Million People Points To A Surprising Brain Health Predictor
A meta‑analysis of 27 cohort studies covering more than 4 million participants found that higher cardiorespiratory fitness, measured by VO₂ max, is associated with a 36 % lower risk of depression and a 39 % lower risk of dementia. The relationship held even when...
HHS’ Healthy Food Agenda Puts Hospitals on Notice About Patients’ Meals
The Health and Human Services Department, led by Robert F. Kennedy Jr., is threatening to withhold Medicare and Medicaid payments from hospitals that serve sugary drinks or meals that fall short of the USDA’s 2025‑30 dietary guidelines. HHS issued a...
EU Backs Itvisma Gene Therapy for Spinal Muscular Atrophy
European regulators have issued a positive opinion on Itvisma, Novartis' onasemnogene abeparvovec gene therapy for spinal muscular atrophy (SMA). The Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorisation on 23 April 2026, pending final approval by the European Commission....
How Health Systems Are Tackling 'Kill the Clipboard' Obstacles
In July 2025, more than 60 health systems pledged to CMS to eliminate repetitive patient data entry, a move dubbed “Kill the Clipboard.” The initiative encourages patients to retrieve records from CMS Aligned Networks or personal health‑record apps and share...
Preparing for the 2026 HIPAA Changes: A Practical Guide for Healthcare Leaders
The Department of Health and Human Services will finalize a major overhaul of the HIPAA Security Rule in 2026, turning many previously optional safeguards into mandatory requirements. Organizations will face a tight compliance window—potentially as short as 60 days—once the...
What’s Next for Post-Acute Care: Data, Collaboration and the Path Forward
Post‑acute care is moving from a peripheral concern to a core pillar of health‑plan strategy. Plans are replacing delayed claims with real‑time clinical data, fostering tighter collaboration across hospitals and post‑acute providers, and embracing value‑based payment models that tie reimbursement...
Vantrexa Sets High Standards for Retatrutide Research Materials in Metabolic Studies
Vantrexa, a professional laboratory supplier, is now offering research‑grade Retatrutide (LY3437943), a triple‑agonist targeting GLP‑1, GIP and glucagon receptors, for metabolic studies. The company employs advanced solid‑phase peptide synthesis and rigorous in‑house plus third‑party HPLC/LC‑MS testing, achieving purity levels above...
White House Says It's Cut VA Wait Times, but New Study Paints More Complicated Picture
The White House touts reduced VA wait times after the Trump administration cut roughly 30,000 VA jobs, but a Vet Voice Foundation study of 21 VA medical centers shows wait times rose at 71% of sites and in 64% of...
Rhythm Pharmaceuticals Reports the EC Approval of Imcivree (Setmelanotide) for Acquired Hypothalamic Obesity
Rhythm Pharmaceuticals announced that the European Commission has granted marketing authorization for Imcivree (setmelanotide) to treat acquired hypothalamic obesity in patients aged four years and older. The approval is based on the Phase III TRANSCEND trial, which enrolled 120 participants...
Stay Ahead: Free Weekly Health‑tech Insights for Clinicians
Every week, I track news, studies, trends and announcements that show where medicine and healthcare are really going, from the latest AI breakthroughs and digital health tools to the cultural shifts redefining patient care. The Medical Futurist Newsletter brings you: ✅ Curated...
Novo Nordisk to Launch Ozempic for Type 2 Diabetes in US
Novo Nordisk will launch an oral version of Ozempic in the United States, following FDA approval that marks the first oral GLP‑1 drug cleared for both blood‑sugar control and cardiovascular risk reduction. The tablets, available in 1.5 mg, 4 mg and 9 mg...
€4.8m EU-Funded AI Project to Tackle Child Diarrhoeal Disease in Africa
An EU‑funded CARE‑AFRICA project will develop an AI‑driven tablet tool to identify the pathogen behind diarrhoeal disease in children under five across sub‑Saharan Africa. The €4.8 million (about $5.2 million) grant brings together six partners from Europe and Africa to train models...
High-Intensity Interval Training Shows Strongest Vascular Benefits in Cardiovascular Patients
Researchers at Miguel Hernández University and ISABIAL conducted a systematic review and network meta‑analysis of 37 trials involving 6,818 patients with coronary artery disease or chronic heart failure. The analysis found high‑intensity interval exercise (HIIE) produced the largest gains in...
Independent Evidence Reviews Overturn Insurer Denials Of Healthcare Coverage
Independent clinical reviewers in New York reversed nearly half of health‑insurance claim denials between 2019 and 2025, with 80% of appealed cases resulting in coverage. The findings highlight systemic flaws in prior‑authorization processes that generate millions of denials annually across...
Arvinas and Pfizer Report the US FDA Approval of Veppanu (Vepdegestrant) for ESR1-Mutated Breast Cancer
The U.S. FDA has approved Veppanu (vepdegestrant) for adults with ESR1‑mutated ER+/HER2‑ advanced or metastatic breast cancer who have received at least one line of endocrine therapy. The approval follows the Phase III VERITAC‑2 trial, which compared Veppanu to fulvestrant...
Federal Judge Blocks Kennedy’s Vaccine Reforms
On March 16, U.S. District Judge Brian Murphy issued an injunction that blocks Health Secretary Robert F. Kennedy Jr.’s sweeping revisions to the federal childhood immunisation schedule. The ruling followed a lawsuit by the American Academy of Pediatrics and other...
863: Developing Novel Materials with Wide Applications From Medicine to Manufacturing - Dr. Tim Long
In this episode, Dr. Tim Long, a chemistry professor and director of the Macromolecules Innovation Institute at Virginia Tech, discusses his research on designing novel macromolecular structures that impact fields ranging from chemotherapy to electroactive prosthetic devices. He emphasizes the...
MAHA Vs. The FDA: Dredging up Old Anti-Regulation Revisionist History
A new essay in Science-Based Medicine denounces the “health‑freedom” narrative that seeks to dismantle the FDA. It traces the agency’s authority back to the 1962 Kefauver‑Harris amendment, which linked drug approval to rigorous safety and efficacy trials. The author dismantles...
Joint Call by the President of the ICRC, the Director-General of WHO and the International President of MSF
The International Committee of the Red Cross, World Health Organization and Médecins Sans Frontières jointly warned that UN Security Council Resolution 2286, adopted a decade ago to protect health care in armed conflict, has failed as attacks on hospitals, ambulances and...
65 % of Eligible Lung Cancer Patients Do Not Receive the Most Appropriate Targeted Therapies, Diaceutics Report Finds
Diaceutics’ 2026 Clinical Practice Gaps report shows that 65% of U.S. patients with advanced non‑small cell lung cancer still miss the most appropriate targeted therapy, a figure unchanged since 2019. While biomarker testing has improved, the biggest loss now occurs...
AAD Survey Reveals Americans Ignore Sun Risks Despite Skin Cancer Concerns
The American Academy of Dermatology’s 2026 Practice Safe Sun Survey reveals a stark gap between perceived and actual sun‑protection habits. Although 57 % of Americans say they use sunscreen regularly, one‑third reported a sunburn in the past year and nearly half...
How Can Care Homes Charge Fees After a Death?
Avery Healthcare, which runs over 100 UK care homes, has re‑introduced contract clauses that charge families for up to 14 days after a resident’s death and demand an upfront £595 (~$756) dilapidation fee. These provisions clash with the Competition and...
A Decade After the ‘Godfather of AI’ Said Radiologists Were Obsolete, Their Salaries Are up to $571K and Demand Is...
Ten years after Geoffrey Hinton warned that AI would make radiologists obsolete, the specialty is thriving. The U.S. radiology workforce grew about 10%, while average compensation rose to $571,000 in 2025, a 9% increase year‑over‑year. Demand remains high, with over...
Global Health Systems Unprepared for Unpredictable Cruise Ship Outbreaks
Viruses emerge in all sorts of unpredictable ways. Could be rodents on the ship or human to human transmission enabled by cruise ship environment. Effective responses require functioning health systems that are prepared for anything. We’ve never been less prepared...
Artificial Retina Uses Biological Liquid Medium for Direct-to-Display ‘Vision’
Italian researchers led by Prof. Thomas M. Brown unveiled BIOPIX, a bio‑electronic hybrid retina emulator that embeds organic photodetectors in a liquid Ames medium. The proof‑of‑concept includes a 2 × 2 cone‑type array for colour and a 4 × 4 rod‑type array for grayscale,...
Novel Bioprinting Method Lays the Foundation for Personalised Regenerative Medicine
Researchers in Italy unveiled a solid‑electronics, liquid‑electrolyte sensor array that mimics retinal function, marking a proof‑of‑concept for bio‑integrated vision devices. A cell‑free hydrogel delivering extracellular vesicles showed efficacy in repairing intrauterine adhesions and restoring fertility in preclinical studies. An analysis...
Robotic Fingertips Restore Surgeons' Tactile Feedback
Restoring surgeons’ sense of touch with robotic fingertips By Anthony King / Horizon Magazine https://t.co/71aGOVJwyQ
FDA Action Alert: Argenx, AstraZeneca/Daiichi Sankyo, Biogen/Eisai and Cingulate
May’s FDA docket is light, but the decisions on four high‑profile drugs could reshape market dynamics. Argenx is seeking to broaden Vyvgart’s label to seronegative myasthenia gravis patients, potentially adding 11,000 new users. AstraZeneca and Daiichi Sankyo aim to secure...
Viewpoint: How ‘Health Care Guru’ Joe Rogan Circumvented the FDA’s Skepticism on Psychedelics
Joe Rogan directly messaged President Donald Trump about the therapeutic potential of psychedelics, prompting the president to sign an executive order that fast‑tracks FDA review of these drugs. The order creates a priority‑voucher system that accelerates approvals for psychedelic manufacturers,...
Trump’s America First Health Aid Cuts: Retrenchment Has Already Hit Global Malaria, HIV, TB, and Polio Programs
Under President Donald Trump’s 2025 “America First” agenda, the United States froze a portion of its foreign development aid, prompting the termination of several global health programs. The cuts threaten malaria, HIV, tuberculosis and polio initiatives, with USAID projecting up...
Re: Advances in the Pathophysiology and Treatment of Diabetic Peripheral Neuropathy
In a recent BMJ rapid response, GP Peter J. Lewis highlights that the latest state‑of‑the‑art review on diabetic peripheral neuropathy (DPN) omitted a growing body of evidence linking vitamin D deficiency (VDD) to the condition. He cites studies showing that roughly...
Virtual Medicine's Rise — and Its Malpractice Risks
Virtual care has become a permanent pillar in Canada, jumping from 10‑20% pre‑COVID to 40% in 2021. Regulators such as the CPSO and CNO maintain that the standard of care remains unchanged but require additional technology‑savvy skills. The main malpractice...